NDAQ:MOR - Post Discussion
Post by
whytestocks on Apr 29, 2024 9:15pm
MorphoSys AG Reports First Quarter 2024 Financial Results
Just In: $MOR MorphoSys AG Reports First Quarter 2024 Financial Results– Entered into Business Combination Agreement to be acquired by Novartis for € 68.00 per share in cash, representing a total equity value of € 2.7 billion – Received all mandatory antitrust approvals for the proposed acquisition by Novartis – S...
MOR - MorphoSys AG Reports First Quarter 2024 Financial Results
Be the first to comment on this post